MERCK & CO., INC Rahway, NJ, USA
(known as MSD outside the United States and Canada)

Effective Nov. 20th, 2023 Caraway Therapeutics, Inc.,
a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

View the Announcement Visit

Scientific Advisors

Ivan Dikic
Ivan Dikic, MD, PhD
Co-Founder and Scientific Advisor
Chairman, Institute of Biochemistry II; Founding Director, Frankfurt
Cancer Institute

Ivan Dikic, MD, PhD, is a renowned molecular biologist whose research focuses on deciphering molecular mechanisms of cellular signaling pathways, which have a high relevance to human diseases such as cancer, neurodegenerative disorders, and inflammation.

Dr. Dikic was elected an International Honorary Member of the American Academy of Arts & Sciences. He is a world leader in the study of autophagy and an elected member of the German National Academy of Sciences, European Molecular Biology Organization, and Academic Europea. Dr. Dikic has served as chairman, professor, and director of the Institute of Biochemistry II, and founding director of the Frankfurt Cancer Institute at Goethe University Medical School in Frankfurt. He also was appointed a Group Leader at the Ludwig Institute for Cancer Research in Sweden.

His recognitions and awards include the Leibniz Award, the Jung Prize for Medicine, and the American Society for Biochemistry and Molecular Biology William Rose Award, the Hans Krebs Prize.

Dr. Dikic earned his Doctor of Medicine from the University of Zagreb in Croatia. He also received a doctorate in natural sciences from New York University.